REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Adult Joint Formulary
Home > Formulary : Adult > Recent Decisions > 2019 >

Decisions 18th June 2019

At the meeting on the 18th June the following decisions were agreed:

New Drug Requests

Approved

Espranor® (TLS Green)

Fusidic Acid 2% cream (Fucidin®) (TLS Green)

Shared Care Protocol/TLS change in status 

Dermatonics Once Heel Balm® (Amber no SCP)

  • Change from TLS Blue to TLS Amber SCP

Sodium Valproate (Amber 1 month) 

  • Change from TLS Green to TLS Amber 1 month for women of child-bearing age, SCP pending

 Acamprosate (TLS Blue)

  • Change from TLS Amber to TLS Blue:  To be initiated by prescribers who have received additional training to become competent in this area.

Further work needed

Allpresan® diabetic intensive foam cream (10% urea) (Amber no SCP)

  • The group agreed that further work was needed to develop a heel balm foot care care pathway

  • Update 2020- heel balm pathway now uploaded and emollient guidelines updated - heel balms now TLS Blue